ArticleBMC infectious diseases2026
Construction and validation of a predictive model for mortality risk in patients with Staphylococcus aureus bloodstream infection.
Article in BMC infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
purposeTo establish and validate a predictive model for the risk of death in patients with Staphylococcus aureus (S. aureus) bloodstream infection (BSI) to support clinical decision-making and patient management.
methodsThis study included demographic and clinical data from 206 patients with S. aureus BSI in China from January 2020 to June 2025. Variable selection was performed using Least Absolute Shrinkage and Selection Operator (LASSO) regression. Independent risk factors were then identified by multivariate Cox regression analysis. A prognostic model and corresponding nomogram were constructed. The models were evaluated using bootstrap, the area under the curve (AUC) of Receiver Operating Characteristic (ROC), decision curve analysis (DCA), and calibration curves. Finally, data from 60 patients with S. aureus BSI from other centers were used for external validation of the model.
resultsBased on the results of LASSO regression, the low red blood cell count (RBC), increased age, elevated C-reactive protein (CRP), elevated blood urea nitrogen (BUN), and low platelet counts (PLT) were used to construct the prognostic model. Among the aforementioned factors, the low RBC (hazard ratio [HR] of 0.41; 95% confidence interval [CI],0.22–0.76) and increased age (HR,1.04; 95%CI,1.00–1.07) were found to be independent risk factors for death in patients with S. aureus BSI. The results of bootstrap showed that the model’s bias and C-index were 0.003 and 0.735, respectively. The ROC curve shows that AUC values across three cohorts ranged from 0.724 to 0.831. These three calibration curves show that at 7, 14, and 28 days, the curves fluctuate around the 45°diagonal line. This indicates a good correlation between the actual risk and the predicted risk, demonstrating a high degree of calibration. The DCA curves showed that the model yielded relatively stable clinical net benefits for 28-day mortality risk prediction within the risk threshold range of 10 ~ 25%.
conclusionRBC and age are independent risk factors for 28-day mortality in patients with S. aureus BSI. When combined with CRP, BUN, and PLT, they show certain prognostic predictive value. In patients with S. aureus BSI, our model could facilitate close clinical monitoring, prompt intervention, and improvement of patient prognosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.